Trading Signals: UTHR Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Dec. 22, 2023)( United Therapeutics Corp)
| UTHR latest price $253.2800 (0.06%) ($253.2800 - $256.3500) on Wed. Feb. 15, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.23% (three month average) | RSI | 34 | Latest Price | $253.2800(0.06%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | UTHR declines -1.4% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support UTHR advance at 0% a week (0% probability) XLV(45%) IBB(43%) SPLV(37%) DIA(35%) VYM(35%) | Factors Impacting UTHR price | UTHR will decline at least -0.615% in a week (0% probabilities). VXX(-21%) VIXM(-13%) EDOC(-10%) UUP(-8%) TBT(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.615% (StdDev 1.23%) | Hourly BBV | -0.6 () | Intraday Trend | 0% | | | |
|
Resistance Level | $257.53 | 5 Day Moving Average | $253.76(-0.19%) | 10 Day Moving Average | $254.29(-0.4%) | 20 Day Moving Average | $257.53(-1.65%) | To recent high | -9.7% | To recent low | 0.2% | Market Cap | $11.235b | | | | United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD. |